(2S)-4-Methyl-N-[(2S)-1-[[(2S)-4-Methyl-1-[(2R)-2-Methyloxiran-2-Yl]-1-Oxopentan-2-Yl]Amino]-1-Oxo-3-Phenylpropan-2-Yl]-2-[[(2S)-2-[(2-Morpholin-4-Ylacetyl)Amino]-4-Phenylbutanoyl]Amino]Pentanamide; Kyprolis; Unii-72X6E3J5Ar; Carfilzomib (PR-171); PR-171

Brief Introduction

Carfilzomib is a proteasome inhibitor. Proteasome can decompose proteins that are damaged or no longer needed, thus playing an important role in cell function and growth.

Suppliers

Shanghai Bocimed Pharmaceutical Co.,Ltd.

CNY 39.8 Million

19980m²

100-500 People

CRO CRO

Product Photo	Specification	Grade	Max Capacity	Certificates	Package

	98%	Pharm Grade	-	-	25kg / Fibre Drum

Main products:

Carfilzomib /Relugolix /Ixazomib Citrate /Apalutamide /Avatrombopag /Fulvestrant /Lenvatinib Mesylate /Ruxolitinib Phosphate /Roxadustat /Brivaracetam

Dolutegravir

CAS:1051375-16-6

Molecular Formula:C20H19F2N3O5

Alias

More Information

(4R,12As)-N-(2,4-Difluorobenzyl)-7-Hydroxy-4-Methyl-6,8-Dioxo-3,4,6,8,12,12A-Hexahydro-2H-Pyrido[1',2':4,5]Pyrazino[2,1-B][1,3]Oxazine-9-Carboxamide; S/Gsk1349572; Gsk 1349572; Tivicay; Dtg; Dolutegravir Api; Dolutegravir (Gsk1349572); 2H-Pyrido[1',2'

Brief Introduction

Dolutegravir (DTG) is an FDA-approved drug for the treatment of HIV infection. Dolutegravir is an integrase inhibitor. Known as S/GSK1349572 or just "572" the drug is marketed as Tivicay by GlaxoSmithKline (GSK). In February, 2013 the Food and Drug Administration announced that it would fast track dolutegravir's approval process. On August 13, 2013, dolutegravir was approved by the FDA. On November 4, 2013, dolutegravir was approved by Health Canada. On January 16, 2014, Tivicay was approved by the European Commission for use throughout the European Union.

Suppliers

Liaoyuan Silver Eagle Pharmaceutical Co., Ltd.

CNY 22 Million

49950m²

100-500 People

CRO CRO

Product Photo	Specification	Grade	Max Capacity	Certificates	Package

	WHO	Pharm Grade	-	-	25kg / Fibre Drum

Main products:

Dolutegravir /Sodium 4-Aminosalicylate Dihydrate /Metoclopramide Hydrochloride /Ambroxol Hydrochloride /Ethacridine Lactate Monohydrate /Metoclopramide /Metaraminol Bitartrate /Moxifloxacin Hydrochloride /Sacubitril /2-Chloro-4-Nitrobenzoic Acid /Bictegravir /Methyl 4-Acetamido-2-Methoxybenzoate /Methyl 4-Acetamido-5-Chloro-2-Methoxybenzoate /Bromhexine Hydrochloride /4-Aminosalicylic Acid

Ruxolitinib Phosphate

CAS:1092939-17-7

Molecular Formula:C17H21N6O4P

Alias

More Information

3R)-Cyclopentyl-3-[4-(7H-Pyrrolo[2,3-d]Pyrimidin-4-yl)Pyrazol-1-yl]Propionitrile Phosphate; (R)-3-(4-(7H-Pyrrolo[2,3-d]Pyrimidin-4-yl)-1H-Pyrazol-1-yl)-3-Cyclopentylpropanenitrile Phosphate; Jakafi; Jakavi

Brief Introduction

Ruxolitinib phosphate is a potent JAK1/2 inhibitor with IC50 of 3.3 nM/2.8 nM, respectively, showing 130-fold selectivity over JAK3.

Suppliers

Shanghai Bocimed Pharmaceutical Co.,Ltd.

CNY 39.8 Million

19980m²

100-500 People

CRO CRO

Product Photo	Specification	Grade	Max Capacity	Certificates	Package

	99%	Pharm Grade	-	-	25kg / Fibre Drum

Main products:

Ruxolitinib Phosphate /Relugolix /Carfilzomib /Ixazomib Citrate /Apalutamide /Avatrombopag /Fulvestrant /Lenvatinib Mesylate /Roxadustat /Brivaracetam

Tacrolimus Monohydrate

CAS:109581-93-3

Molecular Formula:C44H71NO13

Alias

More Information

Tacrolimus; Tacrolimus Hydrate; Prograf; Protopic; Tsukubaenolide Hydrate

Brief Introduction

Tacrolimus monohydrate (FK506 monohydrate) is a macrolide compound that binds to the FK506 binding protein (FKBP) to form a complex and inhibits calcineurin phosphatase, thereby inhibiting T lymphocyte signal transduction and IL-2 transcription. Has strong immunosuppressive properties.

Suppliers

Fishfa Biogenics

USD 5 Million

50-100 People

Manufacturing Manufacturing

Specification	Grade	Max Capacity	Certificates	Package

97% to 102%	Pharm Grade	180 tons/year	COA	1kg / Fibre Drum
98.0 % to 102.0%	Pharm Grade	180 tons/year	COA	1kg / Fibre Drum

Main products:

Tacrolimus Monohydrate

Lafutidine

CAS:118288-08-7

Molecular Formula:C22H29N3O4S

Alias

More Information

(Z)-Inyl)Oxy)-2-Butenyl); Lafutidine(Subjecttopatentfree); Protecadin; Enyl)Acetamide; Rac-2-(Furfurylsulfinyl)-N-[(Z)-4-{[4-(Piperidinomethyl)-2-Pyridyl]Oxy}But-2-Enyl]Acetamide; (+/-)-2-(Furfurylsulfinyl)-N-[4-[4-(Piperidinomethyl)-2-Pyridyl]Oxy-(Z)-2-Butenyl]Acetamide; N-(4-(4-Piperidinylmethyl)Pyridyl-2-Oxy)Butenyl-2-(Furfurylsulfinyl)Acetamide; 2-((Furan-2-Ylmethyl)Sulfinyl)-N-(4-((4-(Piperidin-1-Ylmethyl)Pyridin-2-Yl)Oxy)But-2-En-1-Yl)Acetamide; (Z)-2-((Furan-2-Ylmethyl)Sulfinyl)-N-(4-((3-(Piperidin-1-Ylmethyl)Pyridin-2-Yl)Oxy)But-2-En-1-Yl)Acetamide; Adefovir Dipivioxil; (Z)-2-((Furan-2-Ylmethyl)Sulfinyl)-N-(4-((3-(Piperidin-1-Ylmethyl)Pyridin-2-Yl)Oxy)But-2-En-1-Yl);

Brief Introduction

Lafutidine, is a special histamine H2 receptor antagonist with acid inhibition and gastrointestinal mucosal protection. The drug inhibits gastric acid secretion by antagonizing histamine H2 receptor. The blocking ability of histamine H2 receptor is 2-85 times that of traditional histamine H2 receptor antagonists. The acid inhibition effect is strong and lasting, and can continuously inhibit the basic secretion of gastric acid, pepsin, nocturnal secretion, tetrapeptide gastrin, uracholine Gastric acid secretion caused by stimulating factors such as gastric dilation.

Suppliers

Shandong Qidu Pharmaceutical Co.,Ltd.

CNY 90 Million

399600m²

1000+ People

Manufacturer Manufacturing